PRP ricco di leucociti o PRP privo di leucociti contro placebo nel trattamento dell’epicondilite. Studio Clinico Randomizzato controllato in doppio cieco

Title

Code

Epic-PRP

Type

Sperimentale

Start Year

2022

Status

In Corso

Principal Investigator

051-6366968

enrico.guerra@ior.it

Guerra Enrico, MD

Director

Shoulder and elbow Surgery

Operational unit that carry out the study

complex unit

Chirurgia della spalla e del gomito

Director

Guerra Enrico, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. Epic-PRP

Wednesday 12 October 2022, 16:57

PG0015081_2022_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

PRP ricco di leucociti o PRP privo di leucociti contro placebo nel trattamento dell’epicondilite. Studio Clinico Randomizzato controllato in doppio cieco

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

PRP ricco di leucociti o PRP privo di leucociti contro placebo nel trattamento dell’epicondilite. Studio Clinico Randomizzato controllato in doppio cieco

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in